从美国的经验探讨我国制药企业的环境保护社会治理途径  

Social Governance Solutions for Environmental Protection of Chinese Pharmaceutical Companies from US Experience

作　　者：程潇[1] 李捷理[2] 

机构地区：[1]湖北中医药大学管理学院湖北省中医药发展研究中心,武汉430065 [2]美国俄亥俄大学社会学与人类学系,埃森斯45701

出　　处：《医药导报》2016年第5期543-546,共4页Herald of Medicine

基　　金：湖北省高校人文社会科学重点研究基地中医药发展研究中心一般项目"基于中医五行理论的企业逆向物流目标管理模式研究"(ZX2013Y2);2014年湖北省青年教师出国留学基金项目

摘　　要：探讨我国制药企业环境保护问题,总结美国对于制药企业环境保护社会治理的方式,就此提出我国制药企业环境保护社会治理的途径,例如加强生态产权研究,由政府管制为主过渡到政府和市场共同规制;加快制药企业环境信息披露;尝试制药行业内的契约治理;探索环境保护非政府组织的可持续发展机制;倡导科学普及环境保护知识,支持民间自科普等。To explore the problems in environmental governance of pharmaceutical industry in China,based on the conclusion that the US has done,then propose ways for environmental management to be applied to the pharmacutical industry in China,including strengthening the ecological property research;to transite the government regulation to common control by the government and the market;to speed up the disclosure of environmental information about pharmaceutical enterprise;to try contractual governance within the pharmaceutical industry;to explore sustainable development mechanism of the Evironmental Non-governmental Orgnization（ENGO）;to advocate that popularizing of environmental protection knowledge scientific,to support the dissemination of science socialized.

关 键 词：制药企业 环境污染 社会治理 美国经验 

分 类 号：R951[医药卫生—药学]